Comparative effectiveness of biologics and targeted therapies for psoriatic arthritis
Objective To quantify comparative effectiveness of interleukin (IL)−12/23 antagonist (ustekinumab), IL-17A antagonists (secukinumab and ixekizumab), PDE4 inhibitor (apremilast) and tumour necrosis factor-alpha (TNF-α) inhibitors (infliximab, etanercept, adalimumab, certolizumab pegol and golimumab)...
Shranjeno v:
| Principais autores: | , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BMJ Publishing Group
2021-03-01
|
| Serija: | RMD Open |
| Online dostop: | https://rmdopen.bmj.com/content/7/1/e001399.full |
| Oznake: |
Brez oznak, prvi označite!
|